{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:22:24Z","timestamp":1791418944330,"version":"4.3.3"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/cmr.0b013e328311aaa1","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T03:23:35Z","timestamp":1225855415000},"page":"400-404","source":"Crossref","is-referenced-by-count":29,"title":["A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma"],"prefix":"10.1097","volume":"18","author":[{"given":"Agop Y.","family":"Bedikian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vardeleon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Deitcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/bjc.1995.430","article-title":"Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models","volume":"72","author":"Webb","year":"1995","journal-title":"Br J Cancer"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s002800050846","article-title":"Preclinical pharmacology, toxicology and efficacy of sphingomyelin\/cholesterol liposomal vincristine for therapeutic treatment of cancer","volume":"42","author":"Webb","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0091270006288953","article-title":"Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients","volume":"46","author":"Bedikian","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"R7-4-20210129","first-page":"23","article-title":"Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma","volume":"21","author":"Buzaid","year":"1994","journal-title":"Semin Oncol"},{"key":"R8-4-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0305-7372(74)80020-4","article-title":"Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma","volume":"1","author":"Comis","year":"1974","journal-title":"Cancer Treat Rev"},{"key":"R9-4-20210129","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/cncr.20183","article-title":"A phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study","volume":"100","author":"Whitehead","year":"2004","journal-title":"Cancer"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00001813-200501000-00007","article-title":"Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma","volume":"16","author":"Jimeno","year":"2005","journal-title":"Anti-Cancer Drugs"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<584::AID-CNCR14>3.0.CO;2-#","article-title":"A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma","volume":"88","author":"Feun","year":"2000","journal-title":"Cancer"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.iio.0000195852.08453.de","article-title":"Metastatic uveal melanoma therapy: current options","volume":"46","author":"Bedikian","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00008390-200112000-00006","article-title":"Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma","volume":"11","author":"Neale","year":"2001","journal-title":"Melanoma Res"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CMR.0b013e328311aaa1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:14:02Z","timestamp":1786036442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008390-200812000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e328311aaa1","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}